English
Spanish
French
Italian
German
NEWS
Latest News
Turning Action Plans Into Power: Personalizing Care for Patients With Hidradenitis Suppurativa
December 16, 2025
Learn how personalized action plans can empower patients with hidradenitis suppurativa by improving communication, clarifying flare management, and supporting more proactive, individualized care.
Read more
Hot Off the Press: SHSA 2025 Abstracts Published in Dermatology & Therapy
December 1, 2025
The full collection of abstracts presented at the 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA) has officially been published in the open access journal Dermatology & Therapy. This milestone release makes the latest HS research from international clinicians and scientists widely available to the community.
Read more
Why HS Is So Often Misdiagnosed, With Steven Daveluy, M.D.
November 25, 2025
Many people with Hidradenitis Suppurativa (HS) suffer in silence — not because the disease is rare, but because it’s too often misunderstood. In a revealing interview, Dr. Steven Daveluy uncovers the myths, missed signals and clinical blind spots that delay diagnosis and care.
Read more
Danby Research Grant Supports New Insights into HS
November 18, 2025
Support from the HS Foundation’s Danby Research Grant enabled Dr. Fang’s work examining the cellular mechanisms involved in HS. Her findings are helping to clarify how immune structures form in the skin and may inform future targeted treatment approaches.
Read more
Optimizing HS Visits: A Dermatologist’s Guide to Compassionate, Effective Care
November 16, 2025
Pain, stigma, and delays still too often define the journey for patients with Hidradenitis Suppurativa (HS). This feature HSF leader, Dr. Gretchen Roth, in the Dermatologist offers dermatologists a roadmap to turn HS visits into moments of trust-building, actionable care, and real hope. From empathetic communication to tailored management strategies, learn how one clinic’s compassion driven approach can reshape outcomes for this complex condition.
Read more
Surgical Collaboration Strengthens HS Outcomes Across Disease Stages
November 4, 2025
Surgery is not just a last resort for Hidradenitis Suppurativa (HS) anymore. New collaborative models between dermatologists, surgeons and researchers are transforming outcomes across all disease stages, from localized cases to advanced disease. Discover how this multidisciplinary shift is redefining HS treatment.
Read more
Alexa Kimball, MD, on the Future of HS Care
October 22, 2025
Dr. Alexa Kimball shares insights on the future of hidradenitis suppurativa care — from earlier diagnosis and better treatment strategies to integrating comorbidities into research. She also explores emerging therapies like GLP-1 receptor agonists and what’s next for advancing HS management.
Read more
Recognizing HS: From First Signs to an Accurate Diagnosis
October 16, 2025
Hidradenitis suppurativa is often misunderstood and underdiagnosed—even though its telltale signs can emerge early. Explore how key symptoms like painful nodules, abscesses, and draining tunnels can offer a pathway to timely diagnosis and more compassionate, effective care.
Read more
Beyond the Surface: October 2025
October 10, 2025
This month’s newsletter features exciting updates on the new HS Buddy Program, details for SHSA 2025 in Nashville, current grant opportunities, and the latest HS in the News. Don’t miss what’s happening in the HS community — check it out now!
Read more
Can Quitting Smoking Lower the Risk of Hidradenitis Suppurativa?
September 29, 2025
A new study of more than 6 million people shows that quitting smoking can cut the risk of hidradenitis suppurativa by about one-third—but the benefits appear only after staying smoke-free for at least three years. Relapsing, however, brings the risk right back up.
Read more